P47

Clinical trials for P47 explained in plain language.

Never miss a new study

Get alerted when new P47 trials appear

Sign up with your email to follow new studies for P47, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New gene therapy could help people with rare immune disorder fight infections

Disease control ENROLLING_BY_INVITATION

This study tests a new gene therapy for people with chronic granulomatous disease (CGD), a genetic disorder that makes them prone to severe infections. The treatment takes the patient's own stem cells, adds a missing gene in the lab, and puts them back into the body. The goal is …

Matched conditions: P47

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated May 17, 2026 04:09 UTC

P47

Get alerted when new P47 trials appear

New gene therapy could help people with rare immune disorder fight infections